Dare Bioscience, Inc. (DARE) SEC Filing 8-K Material Event for the period ending Tuesday, March 5, 2019

Dare Bioscience, Inc.

CIK: 1401914 Ticker: DARE

View differences made from one to another to evaluate Dare Bioscience, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Dare Bioscience, Inc..


Assess how Dare Bioscience, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Dare Bioscience, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Dare Bioscience, Inc. provided additional information to their SEC Filing as exhibits

Ticker: DARE
CIK: 1401914
Form Type: 8-K Corporate News
Accession Number: 0001401914-19-000008
Submitted to the SEC: Tue Mar 05 2019 8:45:39 AM EST
Accepted by the SEC: Tue Mar 05 2019
Period: Tuesday, March 5, 2019
Industry: Pharmaceutical Preparations
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: